Completed NA INTERVENTIONAL 2-arm NCT04245293

Clinical Trial Study To Evaluate The Performance And Safety Of Ainara®

Open, Comparative Study To Evaluate The Performance And Safety Of The Medical Device AINARA® Vaginal Gel Versus A Hyaluronic Acid-Based Gel In Late Menopausal Transition Women Affected By Vaginal Dryness

Sponsor: Italfarmaco

Conditions Vaginal Disease

Interventions Ainara HyaloGin

Updated 5 times since 2020 Last updated: Jan 27, 2020 Started: Apr 11, 2019 Primary completion: Nov 22, 2019 Completion: Nov 22, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04245293, this NA trial focuses on Vaginal Disease and remains completed. Sponsored by Italfarmaco, it has been updated 5 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Italfarmaco
Opera CRO, a TIGERMED Group Company

Data source: Italfarmaco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Timișoara, Romania